SHIFT Newsroom · GLOBAL

GLP-1 Receptor Agonists and Rotator Cuff Repair Outcomes

Research explores the impact of glucagon-like peptide-1 (GLP-1) receptor agonists on postoperative outcomes following rotator cuff repair.

Published 2026-09-13 · Evidence level 2

Research published on Europe PMC explores the impact of glucagon-like peptide-1 (GLP-1) receptor agonists on postoperative outcomes following rotator cuff repair. The study's findings may have implications for patients undergoing this type of surgery.

What this means in the UK

This research may be relevant to UK patients undergoing rotator cuff repair surgery, as it investigates the potential benefits of GLP-1 receptor agonists on postoperative outcomes.

Known facts

  • GLP-1 receptor agonists are being studied for their impact on postoperative outcomes following rotator cuff repair.

Sources and evidence

← Back to SHIFT Newsroom